Related Experiment Video
Updated: Aug 9, 2026
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Novel SPR mutation in first Chinese patient with sepiapterin reductase deficiency: urinary biomarker validation in
Xiaosheng Zheng1, Chenxin Ying1, Fei Xie2
1Department of Neurology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Background:
Sepiapterin reductase deficiency (SRD) is a rare disorder characterized by motor and cognitive symptoms, where early diagnosis and treatment can significantly improve patient outcomes.
Methods:
We performed genetic analysis, functional studies including Western blot and immunocytochemistry, and urinary sepiapterin measurements in a Chinese patient presenting with levodopa-responsive dystonia and parkinsonism.
Results:
We identified a novel homozygous mutation (c.380 A > T, p.N127I) in the SPR gene. Functional studies demonstrated reduced expression of the mutant protein while maintaining normal subcellular localization, confirming its pathogenicity. Additionally, we detected elevated urinary sepiapterin levels in this patient, who represents the oldest documented case receiving levodopa treatment.
Conclusions:
This study not only expands the genetic spectrum of SRD but also validates the utility of urinary sepiapterin as a reliable, non-invasive diagnostic biomarker, even in older treated patients.
More Related Videos
06:48Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
Published on: April 29, 2022
04:33Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging
Published on: December 8, 2023
